Literature DB >> 6050885

Metronidazole in human infections with syphilis.

A H Davies.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6050885      PMCID: PMC1047883          DOI: 10.1136/sti.43.3.197

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  4 in total

1.  TREATMENT OF VINCENT'S STOMATITIS WITH METRONIDAZOLE.

Authors:  A H DAVIES; J A MCFADZEAN; S SQUIRES
Journal:  Br Med J       Date:  1964-05-02

2.  THE TREATMENT OF VINCENT'S DISEASE WITH METRONIDAZOLE.

Authors:  D L SHINN; S SQUIRES; J A MCFADZEAN
Journal:  Dent Pract Dent Rec       Date:  1965-04

3.  An oral treatment for trichomonal vaginitis. An evaluation of metronidazole.

Authors:  M SCOTT-GRAY; M MURRELL
Journal:  Practitioner       Date:  1961-02

4.  Absorption and excretion of metronidazole. I. Serum concentration and urinary excretion after oral administration.

Authors:  P O KANE; J A McFADZEAN; S SQUIRES; A J KING; C S NICOL
Journal:  Br J Vener Dis       Date:  1961-12
  4 in total
  15 in total

1.  Trichomonas vaginalis. II. Laboratory investigations in trichomoniasis.

Authors:  R Nielsen
Journal:  Br J Vener Dis       Date:  1973-12

2.  Pharmacokinetics of metronidazole as determined by bioassay.

Authors:  E D Ralph; J T Clarke; R D Libke; R P Luthy; W M Kirby
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

3.  A note on the effect of metronidazole on the Nichols strain of Treponema pallidum in vitro and in vivo.

Authors:  A E Wilkinson; P Rodin; J A McFadzean; S Squires
Journal:  Br J Vener Dis       Date:  1967-09

4.  Treatment of anaerobic infections with metronidazole.

Authors:  F P Tally; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

5.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  In vitro resistance of Neisseria gonorrhoeae to metronidazole.

Authors:  T T Yoshikawa; S Miyamoto; A W Chow; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

Review 7.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 8.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

Review 9.  Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

10.  Pyruvate oxidation by the Reiter strain of Treponema phagedenis.

Authors:  H A George; R M Smibert
Journal:  J Bacteriol       Date:  1982-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.